Elicio Therapeutics, Inc. (ELTX)
2.98
-0.06
(-1.97%)
USD |
NASDAQ |
Aug 24, 16:00
2.98
0.00 (0.00%)
After-Hours: 20:00
Elicio Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | 86.16% |
| December 31, 2021 | 97.47% |
| September 30, 2021 | 85.14% |
| June 30, 2021 | 61.85% |
| March 31, 2021 | 58.22% |
| Date | Value |
|---|---|
| December 31, 2020 | 40.74% |
| September 30, 2020 | 40.87% |
| June 30, 2020 | 31.00% |
| March 31, 2020 | 35.95% |
| December 31, 2019 | 37.64% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Precigen, Inc. | 94.32% |
| Agenus, Inc. | 98.50% |
| Amgen, Inc. | 72.08% |
| Anika Therapeutics, Inc. | 65.15% |
| BioCryst Pharmaceuticals, Inc. | 98.01% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.37K% |
| Return on Assets | -137.4% |
| Return on Invested Capital | -218.1% |
| Return on Net Operating Assets | -627.9% |